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Background: Numerous attempts have been made to establish and develop tumor markers that could determine
the susceptibility of normal tissues to transform into cancerous ones. To determine whether altered expression
patterns of E-cadherin could be an early event in the progression of potentially malignant disorders to oral
squamous cell carcinoma, this study aimed to assess the relationship between the immunoexpression of E-cadherin
and the different degrees of epithelial dysplasia in oral leukoplakia.
Methods: Surgically excised specimens from patients with oral leukoplakia (n = 31), oral cavity squamous cell
carcinoma with cervical lymph node metastasis (n = 12) and normal oral mucosa (n = 9) were immunostained for
E-cadherin. Oral leukoplakia samples were distributed into low and high risk group according to a binary system for
grading oral epithelial dysplasia. Comparative analyses between E-cadherin expression and microscopic features
(WHO histological grading and epithelial dysplasia) were performed by Pearson Chi-square test (P < 0.05).
Results: Differences in E-cadherin expression were observed between normal oral mucosa and low risk oral
leukoplakia (P = 0.006), low and high risk oral leukoplakia (P = 0.019), and high risk oral leukoplakia and oral cavity
squamous cell carcinoma with cervical lymph node metastasis (P = 0.0001). In addition, as epithelia undergo
dysplastic changes, the risk of malignant transformation increases, and there is a reduction or loss of E-cadherin
expression by keratinocytes. Reduced E-cadherin expression was an early phenomenon and it was observed in
moderate-severe dysplasia, showing that the loss of epithelial cohesion may be an indicator of progression to oral
cavity squamous cell carcinoma.
Conclusions: E-cadherin could be used as a novel biomarker to identify lesions with potential risk for malignant
transformation, which may provide opportunities for prophylactic interventions in high risk patient groups.
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Potentially malignant disorders include all clinical pre-
sentations that carry a higher risk of cancer when com-
pared to healthy tissue. Much attention has been
focused on oral leukoplakia (OL) due to its high inci-
dence and potential for malignant transformation. The
rates of malignant change vary based in part on the popu-
lation, gender, tobacco habits and histological grading of* Correspondence: sandra.zeidler@ufes.br
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unless otherwise stated.dysplasia [1-3]. Oral epithelial dysplastic lesions may be
morphological phenotypes of the different steps in the
progression from normal to malignant tissue. Tradition-
ally, oral epithelial dysplasia has been considered to be the
progenitor for malignant changes [4]. The World Health
Organization (WHO) grades oral epithelial dysplasia as
mild, moderate or severe based on the importance of cel-
lular atypia and the thickness of the dysplastic layers com-
pared with the total epithelial height [5]. Therefore, the
accurate assessment of the degree of dysplasia in oral le-
sions that potentially reflect malignant disease is quite
challenging and creates barriers for the prediction andtral. This is an Open Access article distributed under the terms of the Creative
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with similar histological phenotypes may present with dif-
ferent biological behavior. Nevertheless, the histopatho-
logical grading of epithelial dysplasia remains the one of
the most clinically important predictors of the malignant
potential of a lesion [1,2,7].
There have been numerous attempts to establish or
even develop tumor markers to determine the suscepti-
bility of normal tissues to transform into cancer [8-11].
Malignant transformation in many carcinomas is associ-
ated with the loss of epithelial phenotype and decreased
differentiation. During this process, epithelial cells reorga-
nize their cytoskeleton acquiring a mesenchymal phenotype,
a process known as epithelial to mesenchymal transition
(EMT). The expression of mesenchymal genes is often ac-
companied by loss of epithelial characteristics, including
reduced inter-cellular adhesion, loss of epithelial cell polari-
ty and increased motility. These EMT features are seen in
oral epithelial dysplasia and in their progression to cancer
[12,13]. Cell adhesion molecules play more than a purely
structural role within stratified squamous epithelia. There
is a strong relationship between reduced expression of
these adhesion molecules, decreased differentiation and in-
creased invasiveness [8,10,14-18].
The cadherins are a family of homophilic cell adhesion
proteins that are expressed in a variety of tissues and re-
quire Ca2+ binding for their adhesiveness, rigidity and
stability. E-cadherin is a cell membrane-associated pro-
tein involved in cell-cell adhesion, and it is generally
localized to the lateral surfaces of epithelial cells in a re-
gion of cell-cell contact that is known as the adherens
junction. As an intercellular adhesion molecule, E-cadherin
plays an important role in establishing and maintaining
intercellular connections and by directly eliciting signals
involved in tissue morphogenesis for epithelial integrity.
E-cadherin is the key player in inducing cell polarity and
organizing the epithelium. The exact mechanism that
normal oral epithelium becomes a dysplastic tissue is not
known. However, it has been shown that E-cadherin
mediated-cell-cell adhesion can regulate important cell sig-
naling pathways influencing mechanisms of proliferation,
differentiation, as well as apoptosis [19,20]. Moreover,
E-cadherin’s intracellular ligand β-catenin regulates Wnt-
signaling pathway acting as transcriptional activator in-
volved in tumorigenesis; whereas in parallel, it mediates
the cadherin/catenin complex interaction with epidermal
growth factor receptor [21]. Further, dysfunctional E-
cadherin-mediated cell adhesion has been suggested to be
associated with the loss of differentiation and acquisition
of an invasive phenotype and may be used as a potential
biomarker of tissue transformation [22,23].
In most cancers of epithelial origin, including head and
neck squamous cell carcinoma, E-cadherin-mediated
cell-cell adhesion is lost concomitantly with progressiontowards tumor malignancy [20,24-26]. Although some
studies have explored the immunoreactivity of E-cadherin
in potentially malignant disorders, non-tumor epithelium
adjacent to oral cancer and oral squamous cell carcinoma,
it remains unclear if E-cadherin could be used as bio-
marker to predict malignant transformation [10,22,23].
Nevertheless, there have been few reports on the immu-
nohistochemical expression of this protein in oral precan-
cerous lesions with respect to dysplasia grade. In addition,
there is limited data on the usefulness of E-cadherin for
estimating the risk of developing tumors associated with
the progression of the dysplasia-carcinoma sequence in
the oral cavity and on the potential for this molecule to
mediate a signaling pathway driving oral squamous cell
carcinoma growth and invasion.
To determine whether altered expression patterns of
E-cadherin could be an early event in the progression of
potentially malignant disorders to oral squamous cell
carcinoma and invasiveness, this study aimed to assess
the relationship between the immunoexpression of E-
cadherin and the different degrees of epithelial dysplasia
in OL.Methods
Patients and clinical specimens
The samples from this retrospective cohort study con-
sisted of surgically excised specimens from 31 patients
with a clinical diagnosis of OL who were periodically
monitored at Oral Disease Center of Goiás of the Fe-
deral University of Goiás, Brazil. Specimens from 12 oral
cavity squamous cell carcinoma with cervical lymph
node metastasis (OCSCC N+) and 9 individuals with
normal oral mucosa (control) were also included to
compare the pattern of E-cadherin expression. All speci-
mens were retrieved from the archives of the Oral Pa-
thology Laboratory of the Dental School at the Federal
University of Goiás, Brazil. Clinical data (i.e., gender, age,
ethnic group, tobacco and alcohol consumption, lesion/
tumor location and lesion/tumor size) were obtained
from medical records.
The inclusion criteria during this study were patients
of both sexes, over 30 years old, submitted for the surgi-
cal treatment, T2 ⁄ T3 size of the primary tumor or those
with clinical diagnostic of OL. The exclusion criteria
were patients with squamous cell carcinoma in other
sites and those who received radiotherapy, chemother-
apy or any other treatment prior to surgery.
This study was approved by the Institutional Ethics
Committee for Human Subjects of the Araujo Jorge
Hospital, Goiás Combat Cancer Association (Protocol
2010–015). The experiments were undertaken with the
understanding and written consent of each subject
according to the ethical principles.
Table 1 Main clinical findings of patients with OL (n = 31),
OCSCC N+ (n = 12) and controls (n = 9)
Clinical features OL (%) OCSCC N+ (%) Controls (%)
Gender
Male 45.2 83.3 22.2
Female 54.8 16.7 77.8
Tobacco
Yes 80.6 100 0
No 19.4 0 100
Alcohol
Yes 41.9 66.6 0
No 58.1 33.4 100
Anatomic site
Buccal mucosa 58.1 0 88.9
Oral tongue 41.9 100 11.1
OL, oral leukoplakia; OCSCC N+, oral cavity squamous cell carcinoma with
cervical lymph node metastasis.
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All specimens were fixed in 10% buffered formalin (pH 7.4)
and were then paraffin embedded. The microscopic fea-
tures of the samples were evaluated from the analysis of
one 5-μm section of each sample, which was stained with
hematoxylin and eosin. Epithelial dysplasia was graded ac-
cording to the WHO classification (2005) [5]. Using a bi-
nary system for grading oral epithelial dysplasia, OL were
distributed into a low risk (observation of less than four
architectural changes or less than five cytological changes)
and high risk (based on observing at least four architectural
changes and five cytological changes) group [27]. The archi-
tecture features noted were as follows: irregular epithelial
stratification, loss of basal cell polarity, drop-shaped rete
ridges, increased number of mitotic figures, abnormally
superficial mitoses, premature keratinization in single cells
and keratin pearls within rete ridges. The cytology changes
included the following: abnormal variation in nuclear and
cellular size and shape, increased nuclear-cytoplasmic ratio,
increased nuclear size, atypical mitotic figures, increased
number and size of nucleoli and hyperchromatism. All of
the OCSCC sections were graded according to the WHO
classification of tumors [5].
Immunohistochemistry
Paraffin-embedded tissues were sectioned (3 μm) and
collected in series on glass slides coated with 2% 3-
aminopropyltriethsilane (Sigma-Aldrich, St Louis, MO,
USA). Following deparaffinization by immersion in xy-
lene, the sections were immersed in alcohol and incu-
bated with 3% hydrogen peroxide for 40 min. To
retrieve antigens, the sections were immersed in citrate
buffer (pH 6.0) for 20 min. Afterwards, the sections were
incubated for 20 min with 3% normal goat serum at
room temperature. The slides were incubated at 4°C
overnight with the primary antibody monoclonal mouse
anti-E-Cadherin human (SPM471, Spring Bioscience,
Pleasanton, CA, USA) at 1:200 in a humidifier. After wash-
ing with Phophate Buffered Saline, the sections were la-
beled with TrekAvidin-HRP Label (STHRP700 L10; Biocare
Medical, Concord, CA, USA) and then incubated with 3,3’-
diaminobenzidine (K3468; DAKO, Glostrup, Denmark) for
2–5 min at room temperature. The sections were then
stained with Mayer’s hematoxylin and covered (Entellan-
Mikroskopie-Merck, Darmstadt, Germany). Negative con-
trols were obtained through the omission of primary
antibody, and normal oral mucosa samples with known
positive reactivity were included as positive controls.
Cell counting and statistical analysis
The analysis of E-cadherin immunoexpression was car-
ried taking in count the percentage of positive staining
cells in relation to the whole examined area. A semi-
quantitative scoring system was used, which was basedon the characteristic staining pattern on a four-point
scale: 0, negative with absent or discontinued membran-
ous staining; 1, weak with 1-50% of cell staining; 2, mo-
derate with 51-75% of cell staining and 3, strong with
more than 75% of cells staining. A total index score was
obtained by adding the results of all layers (basal, para-
basal and keratinized) in the groups with normal oral mu-
cosa and OL; tumor front was analyzed at OCSCC N+
group. Epithelial cells were considered positive if they had
the evidence of brown membranous staining. Cell counts
were performed by one investigator in ten alternate
microscopic high-power fields (x400) using an integration
graticule (Standard 20 ZEISS; Carl Zeiss, Gottingen,
Germany).
Comparative analyses between E-cadherin expression
and microscopic features (WHO histological grading
and epithelial dysplasia) were performed using the Pear-
son Chi-square test. The level of statistical significance
was accepted at P < 0.05.
Results
The cases analyzed were distributed into the following
groups: OL (n = 31), OCSCC N+ (n = 12) and control
(n = 9), and the mean age of the groups was 50.9 years
(CI = 31–79), 56.4 years (CI = 42–80) and 20.6 years
(CI = 17–27), respectively. Patients with oral leukoplakia
were monitored in a period, which ranged from 6–18
months (mean 12.4 months), and during this period ma-
lignant transformation was not observed. All OCSCC
cases had T2/T3 staging, and the presence of lymph
node metastasis was confirmed microscopically. The
other features of our series are summarized in Table 1.
After microscopic evaluation, OL samples were classi-
fied using the binary system [27]. Low risk corresponded
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(n = 23), while 8 cases were classified as high risk and
corresponded to cases of OL with moderate or severe
epithelial dysplasia. All OCSCC cases were moderately
or poorly differentiated (grades II-III).
Differences in the E-cadherin expression were ob-
served between all groups (P = 0.0001). In normal oral
mucosa E-cadherin immunohistochemical staining was
observed predominantly in the basal and parabasal layers,
showing a continuous and homogeneous staining, while
marking was discontinuous or absent in the upper third
of the oral epithelium (Figure 1A-B). No labeling was
observed in the cytoplasm or keratinized layer. Semi-
quantitative analysis revealed a score of 3 in the labeled
cells of the control group (Table 2).
In the low risk OL group (n = 23), a reduction in the
E-cadherin expression was observed mainly in the para-
basal layer when compared to the normal oral mucosa
(P = 0.006) (Figure 1C-D). Through semi-quantitative
analysis scores 2 and 3 were obtained (Table 2). However,
in the high risk OL group (n = 8), the E-cadherin expres-
sion was reduced in all epithelial layers (Figure 1E-F).
Scores 1 and 2 were obtained from semi-quantitative ana-
lysis and a significant reduction in E-cadherin expression
compared to the low risk OL group (P = 0.019) was ob-
served (Table 2).
In the OCSCC N+ group (n = 12), there was a reduc-
tion in E-cadherin expression in the cell membrane of
the neoplastic cells in the tumor invasion front. In
addition, cytoplasmic and nuclear staining was noted
(Figure 1G-H). Scores 0 and 1 were obtained in the
OCSCC N+ group (Table 2). It is noteworthy that strong
staining of keratin pearls was found and not considered
to be positive staining. A positive E-cadherin score was
noted for all groups listed in Table 2.
Discussion
The presence and severity of dysplasia in a potentially
malignant oral lesion is currently the standard in pre-
dicting the risk of malignant transformation [3,4]. Stu-
dies have noted that pre-cancerous lesions with
epithelial dysplasia develop into cancer more readily
than lesions without such dysplasia [1,11], while others
have shown that dysplasia regressed with time [7].
Malignant transformation may also take place in non-
dysplastic leukoplakia, and there is currently no informa-
tion available in the literature considering differences in
the behavior or risk of malignant transformation [2,6,7].
Malignant transformation in many carcinomas is asso-
ciated with the loss of epithelial differentiation and a
gain in a mesenchymal phenotype, which has been de-
scribed in events associated with embryogenesis, healing
and metastasis [13]. Recent studies suggest that epithe-
lial to mesenchymal transition may be a predictor ofOCSCC progression and prognosis [8,12]. The expres-
sion of mesenchymal genes with carcinoma progression
is often accompanied by an increase in cell motility and
the loss of epithelial features, including reduced intercel-
lular adhesion and a loss of epithelial cell polarity. These
features are observed in cases of not only OCSCC pro-
gression but also oral epithelial dysplasia. These changes
may be found early in the development of OCSCC, and
the identification of genes and their products that play a
role in the transition process may be potential bio-
markers of malignant transformation [8,9]. One of the
functions of E-cadherin appears to be the control of cell
motility during embryogenesis or tissue healing, with the
downregulation of E-cadherin allowing for migration of
regenerating epithelium over the area of ulceration [19].
This role in the control of cell motility has led to the
suggestion that E-cadherin is an ‘invasion suppressor’
molecule and that in carcinogenesis, loss of E-cadherin
permits or enhances the invasion of adjacent normal
tissue [10,20].
This study used immunohistochemistry to quantify
and analyze expression patterns of E-cadherin in normal
oral mucosa, oral epithelial dysplasia and OCSCC N+ to
investigate the role of this molecule in oral carcinogenesis
and its ability to predict transformation in potentially ma-
lignant lesions. Normal oral mucosa was used as a posi-
tive control, showing strong expression of E-cadherin
particularly in basal and parabasal layers. This suggests
an important role of E-cadherin in the unchanged his-
topathophysiology and maintenance of epithelial tissue
structure [22]. The expression of E-cadherin in the low
risk OL group was similar to the control group, as also
described by Williams et al. (1998) [23]. Our results
showed greater loss or interruption of the adhesion mo-
lecule E-cadherin in the cell membrane in high risk OL
groups and OCSCC N+ compared to low risk OL groups
and normal oral mucosa (Table 2). Furthermore, the re-
duction in E-cadherin expression with increasing severity
of histopathological dysplasia grading was also observed.
Previous studies have found E-cadherin expression to
be significantly reduced in dysplastic oral mucosa and
OCSCC [8,15,17,18], considering that loss of cohesion is
one of the key features of dysplasia. Also recently pub-
lished data by Freitas Silva et al. [21] reinforced our fin-
dings by demonstrating E-cadherin downregulation leading
to phenotypic changes in early stages of oral carcinogen-
esis. It is believed that the E-cadherin downregulation is
the central event of EMT, as it promotes loss of cell-cell
contacts as a key step during cancer progression and me-
tastasis allowing the neoplastic cells to move through the
extracellular matrix. The loss of E-cadherin function du-
ring tumor progression can be caused by various genetic
or epigenetic mechanisms. In most cases, E-cadherin ex-
pression is downregulated at the transcriptional level [20].
Figure 1 (See legend on next page.)
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Figure 1 Immunohistochemical E-cadherin expression in oral normal mucosa, oral leukoplakia and oral cavity squamous cell
carcinoma. (A, B) intense membranous E-cadherin expression in the basal and parabasal layers in normal oral mucosa; (C, D) show reduced
E-cadherin expression in the parabasal layer in low risk oral leukoplakia; (E, F) illustrate the decrease in E-cadherin expression in all oral epithelial
layers in high risk oral leukoplakia; (G, H) show a moderately differentiated OCSCC with loss of E-cadherin expression in the cell membrane of the
neoplastic cells in the tumor invasion front; cytoplasmic and nuclear staining were observed (arrow); (I, J) Negative control. Immunohistochemical
staining, original magnifications; x200 (A, C, E, G, I) and x400 (B, D, F, H, J).
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the E-cadherin gene locus is epigenetically silenced by
hypermethylation, leading to further downregulation of E-
cadherin expression. Additionally, there are some evidence
that both Twist and p-Akt were associated with E-
cadherin downregulation and loss of cell-to-cell adhesion
in EMT [21]. Our results also show that in a high percent-
age of samples from OCSCC N+, loss of E-cadherin ex-
pression in the membrane was associated with the
cytoplasmic and nuclear expression of this protein by neo-
plastic cells. While other authors have also shown similar
results [16,25], the intensity and frequency of the cytoplas-
mic expression of E-cadherin by neoplastic cells remains
controversial [23,28]. Therefore, additional studies are
needed in order to clarify the mechanisms by which the
reduction and loss of E-cadherin expression during ma-
lignant transformation occurs.
In addition, reduced expression of E-cadherin is asso-
ciated with carcinomas that have a striking infiltration
growth pattern, show poor differentiation, develop metas-
tases and carry a poor prognosis [14,16,24,26,29]. Thus,
analyzing moderately and poorly differentiated OCSCC
with nodal involvement reduced membranous E-cadherin
expression was observed, along with high cytoplasmic
E-cadherin expression and eventual nuclear staining
(Figure 1G-H). Loss of E-cadherin function elicits active
signals that support tumor-cell migration, invasion and
metastatic dissemination and it may be involved in the in-









Control - - - 100 0.006*
LR OL - - 52.18 47.82
LR OL - - 52.18 47.82 0.019*
HR OL - 12.50 87.50 -
HR OL - 12.50 87.50 - 0.0001*
OCSCC N+ 33.34 66.66 - -
ǂPearson Chi-square test, P = 0.0001.
*Represents a statistically significant difference within the paired groups
(Pearson Chi-square test). LR OL, low risk oral leukoplakia; HR OL, high risk oral
leukoplakia; OCSCC N+, oral cavity squamous cell carcinoma with cervical
lymph node metastasis.also observed that increased cytoplasmic E-cadherin was
associated with clinical and nodal stage [16]. Furthermore,
altered E-cadherin expression has been related to metasta-
ses, as it favors cell locomotion, proteolysis, survival and
proliferation in primary and distant sites [30]. However,
some studies have not observed a correlation between the
pattern of staining and the histological grade of the tumor,
suggesting that loss of E-cadherin is not necessary for the
acquisition of the malignant phenotype [10]. These data
were supported by in vitro studies where an increased in-
filtrative or invasive potential was associated with low
levels of E-cadherin expression, while non-invasive but
still malignant lines showed high E-cadherin expression
levels [24]. It is possible that E-cadherin could be present
but non-functional. Further studies should concentrate on
the role of E-cadherin in modulating the behavior of cells.Conclusions
In summary, reduced E-cadherin expression was an early
phenomenon, as we observed it in moderate-severe dys-
plasia, suggesting that loss of epithelial cohesion may be
an indicator of possible evolution. Further, as epithelia
undergo dysplastic changes and the risk of malignant
transformation increases, there is a reduction in or loss
of E-cadherin expression by keratinocytes. Therefore,
E-cadherin could be used as a novel biomarker to iden-
tify OL lesions at increased risk for transformation,
which may provide opportunities for prophylactic inter-
vention in high risk patient groups.
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